TY - JOUR
T1 - Treatment of Brain Metastases from Melanoma
AU - McWilliams, Robert R.
AU - Brown, Paul D.
AU - Buckner, Jan C.
AU - Link, Michael J.
AU - Markovic, Svetomir N.
PY - 2003/12
Y1 - 2003/12
N2 - Brain metastases from malignant melanoma have a poor prognosis, and treatment can be difficult because of rapid progression of the disease. To help define the treatment of this disease, we reviewed the published literature on brain metastases from melanoma. If a solitary metastasis is present, surgery might be beneficial, especially if systemic disease is absent. Stereotactic radiosurgery is a less invasive, attractive option for solitary or oligometastatic (up to 6) lesions. External beam whole-brain radiation therapy can produce responses and frequently palliates symptoms, but as the sole therapy, it is unlikely to eradicate brain metastases. Chemotherapy may be gaining a role with newer agents that penetrate the blood-brain barrier. Combined modality therapy appears to be the future direction of treatment of multiple metastases.
AB - Brain metastases from malignant melanoma have a poor prognosis, and treatment can be difficult because of rapid progression of the disease. To help define the treatment of this disease, we reviewed the published literature on brain metastases from melanoma. If a solitary metastasis is present, surgery might be beneficial, especially if systemic disease is absent. Stereotactic radiosurgery is a less invasive, attractive option for solitary or oligometastatic (up to 6) lesions. External beam whole-brain radiation therapy can produce responses and frequently palliates symptoms, but as the sole therapy, it is unlikely to eradicate brain metastases. Chemotherapy may be gaining a role with newer agents that penetrate the blood-brain barrier. Combined modality therapy appears to be the future direction of treatment of multiple metastases.
UR - http://www.scopus.com/inward/record.url?scp=0345293093&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0345293093&partnerID=8YFLogxK
U2 - 10.4065/78.12.1529
DO - 10.4065/78.12.1529
M3 - Review article
C2 - 14661682
AN - SCOPUS:0345293093
SN - 0025-6196
VL - 78
SP - 1529
EP - 1536
JO - Mayo Clinic Proceedings
JF - Mayo Clinic Proceedings
IS - 12
ER -